Advertisement
U.S. Markets open in 2 hrs 48 mins

XBiotech Inc. (XBIT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.86+0.03 (+0.44%)
At close: 04:00PM EST
6.86 0.00 (0.00%)
After hours: 04:02PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 209.12M
Enterprise Value 36.00M
Trailing P/E 1.30
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.23
Price/Book (mrq)1.09
Enterprise Value/Revenue -70.30
Enterprise Value/EBITDA -1.60

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.96
52 Week Low 33.60
50-Day Moving Average 37.22
200-Day Moving Average 37.07

Share Statistics

Avg Vol (3 month) 347.34k
Avg Vol (10 day) 348.51k
Shares Outstanding 530.48M
Implied Shares Outstanding 6N/A
Float 819.84M
% Held by Insiders 135.11%
% Held by Institutions 116.19%
Shares Short (Oct 31, 2024) 4848.3k
Short Ratio (Oct 31, 2024) 422.55
Short % of Float (Oct 31, 2024) 44.76%
Short % of Shares Outstanding (Oct 31, 2024) 42.78%
Shares Short (prior month Sep 30, 2024) 4925.37k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 23, 2021
Ex-Dividend Date 4Jul 15, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-12.03%
Return on Equity (ttm)-15.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -40.57M
Net Income Avi to Common (ttm)-32.66M
Diluted EPS (ttm)-1.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)183.12M
Total Cash Per Share (mrq)6.01
Total Debt (mrq)10M
Total Debt/Equity (mrq)5.20
Current Ratio (mrq)11.57
Book Value Per Share (mrq)6.31

Cash Flow Statement

Operating Cash Flow (ttm)-27.86M
Levered Free Cash Flow (ttm)-22.16M